HK80393A - Pharmaceutical compositions containing calcium salts - Google Patents

Pharmaceutical compositions containing calcium salts Download PDF

Info

Publication number
HK80393A
HK80393A HK803/93A HK80393A HK80393A HK 80393 A HK80393 A HK 80393A HK 803/93 A HK803/93 A HK 803/93A HK 80393 A HK80393 A HK 80393A HK 80393 A HK80393 A HK 80393A
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
compositions containing
calcium salts
containing calcium
calcium
Prior art date
Application number
HK803/93A
Other languages
English (en)
Inventor
Gailly John-Marc
Gomez Daniel
Burguiere Martine
Gens Andre
Remy Jean
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK80393A publication Critical patent/HK80393A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK803/93A 1986-07-01 1993-08-05 Pharmaceutical compositions containing calcium salts HK80393A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8609515A FR2600893B1 (fr) 1986-07-01 1986-07-01 Nouvelles compositions pharmaceutiques a base de sels de calcium

Publications (1)

Publication Number Publication Date
HK80393A true HK80393A (en) 1993-08-13

Family

ID=9336917

Family Applications (1)

Application Number Title Priority Date Filing Date
HK803/93A HK80393A (en) 1986-07-01 1993-08-05 Pharmaceutical compositions containing calcium salts

Country Status (31)

Country Link
US (1) US4867977A (instruction)
JP (1) JPS6322522A (instruction)
KR (1) KR950014449B1 (instruction)
AT (1) AT392588B (instruction)
AU (1) AU597992B2 (instruction)
BE (1) BE1007686A4 (instruction)
CA (1) CA1305057C (instruction)
CH (1) CH674935A5 (instruction)
CY (1) CY1684A (instruction)
DE (1) DE3720510C2 (instruction)
DK (1) DK173508B1 (instruction)
ES (1) ES2006192A6 (instruction)
FI (1) FI89329C (instruction)
FR (1) FR2600893B1 (instruction)
GB (1) GB2192131B (instruction)
GR (1) GR871015B (instruction)
HK (1) HK80393A (instruction)
HU (1) HU199283B (instruction)
IE (1) IE60430B1 (instruction)
IL (1) IL83032A (instruction)
IT (1) IT1216829B (instruction)
LU (1) LU86932A1 (instruction)
MY (1) MY101750A (instruction)
NL (1) NL194749C (instruction)
NO (1) NO175041B (instruction)
NZ (1) NZ220898A (instruction)
PH (1) PH25430A (instruction)
PT (1) PT85212B (instruction)
SE (1) SE502567C2 (instruction)
SG (1) SG123192G (instruction)
ZA (1) ZA874769B (instruction)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621486A5 (instruction) * 1977-01-27 1981-02-13 Fischer Artur
JP2665764B2 (ja) * 1988-04-20 1997-10-22 日水製薬株式会社 カルシウム水溶液剤
EP0346866A3 (en) * 1988-06-16 1990-07-11 Biochemie Gesellschaft M.B.H. Composition for the prophylaxis of osteoporosis
EP0622992B1 (en) * 1991-12-26 1998-10-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
CA2146631C (en) * 1992-10-21 1999-07-20 Alice Lyles Burkes Storage stable calcium-supplemented beverage premix concentrates and syrups
WO1994008472A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Concentrated bioavailable calcium source
WO1994008471A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Sweetener containing a concentrated bioavailable calcium source
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
US5942255A (en) * 1996-07-15 1999-08-24 The University Of Memphis Methods of enhancing lean tissue mass and bone mineral content and compositions therefor
US6235322B1 (en) 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
WO2002098434A1 (es) * 2002-06-27 2002-12-12 Manuel Torres Buendia Metodo para fabricar gluconolactato de calcio, composiciones, procesos y usos del mismo
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
EP1615619A2 (en) * 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
US20040258818A1 (en) * 2003-06-20 2004-12-23 Kraft Foods Holdings, Inc. Reduced acidic flavor in acidified starch products
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US7323201B2 (en) * 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090298946A1 (en) * 2008-06-02 2009-12-03 Cleavelin Cody R Local Anesthetic Deactivation
US11819040B2 (en) 2017-12-20 2023-11-21 Dsm Ip Assets B.V. Materials and methods for dietary calcium supplementation of animals
CA3161557A1 (en) * 2019-12-12 2021-06-17 Alberta Veterinary Laboratories Ltd. Choline bolus compositions for ruminants
CA3120429C (en) 2019-12-12 2021-12-14 Alberta Veterinary Laboratories Ltd. Mineral supplements for ruminant nutrition
CN113749205B (zh) * 2021-09-09 2024-08-06 山东凯翔生物科技股份有限公司 一种葡萄糖酸钙-葡萄糖酸复合粉的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1526981A (en) * 1923-02-02 1925-02-17 Upjohn Co Effervescent alkali compound and process of manufacturing and preparing the same
US1616587A (en) * 1926-08-25 1927-02-08 Upjohn Co Method of manufacturing effervescent alkali compounds
US1765867A (en) * 1928-12-15 1930-06-24 Henry G Granger Method for making candy
US2603569A (en) * 1950-01-23 1952-07-15 Joseph G Alther Effervescent drink concentrate
US2639238A (en) * 1952-07-02 1953-05-19 Joseph G Alther Effervescent drink concentrate
US3082091A (en) * 1956-07-03 1963-03-19 Pierre F Smith Effervescing composition in particle form
US3061445A (en) * 1959-04-30 1962-10-30 Abbott Lab Effervescent sweetening tablet
US3105792A (en) * 1960-11-29 1963-10-01 Warner Lambert Pharmaceutical Stable effervescent compositions and method of preparing same
US3241977A (en) * 1962-01-02 1966-03-22 Gen Foods Corp Effervescent beverage powders
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
US3489572A (en) * 1966-04-04 1970-01-13 Benjamin Eisenstadt Sweetening composition
BE760328A (fr) * 1969-12-15 1971-06-14 Sandoz Sa Nouvelle association medicamenteuse
US3939289A (en) * 1973-04-02 1976-02-17 General Foods Corporation Dry carbonation source for a beverage concentrate and method of preparing the same
US3965273A (en) * 1973-04-02 1976-06-22 General Foods Corporation Dry carbonation source and method for preparing the same, and dry carbonated beverage concentrate
US4237147A (en) * 1974-01-04 1980-12-02 Monsanto Company Stabilized amorphous calcium carbonate
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4009292A (en) * 1975-02-26 1977-02-22 General Foods Corporation Effervescent dipeptide sweetener tablets
US4206244A (en) * 1978-02-06 1980-06-03 Persian Delight, Inc. Dry mix for preparing a carbonated yogurt
JPS5585385A (en) * 1978-12-22 1980-06-27 Mitsuma Miyoshi Powdered food and drink
JPS57122925A (en) * 1981-01-26 1982-07-31 Ajinomoto Co Inc Tablet composition
US4551342A (en) * 1983-02-01 1985-11-05 The Procter & Gamble Company Beverages containing specific cation-edible acid mixtures for improved flavor impression
JPS59166057A (ja) * 1983-03-14 1984-09-19 Ajinomoto Co Inc ジペプチド甘味料含有発泡錠剤の製造法
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4760138A (en) * 1984-12-13 1988-07-26 Nestec S. A. Carbonating agents and their preparation
US4772467A (en) * 1985-02-19 1988-09-20 Board Of Regents, U T Systems Osteoporosis inhibition by dietary calcium supplementation
JPS62501843A (ja) * 1985-02-19 1987-07-23 ボ−ド・オブ・リ−ジェンツ・ザ・ユニバ−シティ−・オブ・テキサス・システム 食事のカルシウム補足によるオステオポロ−シス抑制
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby

Also Published As

Publication number Publication date
IT8748100A0 (it) 1987-06-25
ES2006192A6 (es) 1989-04-16
SE8702712L (sv) 1988-01-02
NO872712D0 (no) 1987-06-29
JPS6322522A (ja) 1988-01-30
ATA164187A (de) 1990-10-15
NZ220898A (en) 1991-04-26
PT85212A (en) 1987-07-01
IE60430B1 (en) 1994-07-13
AU7491387A (en) 1988-01-07
GR871015B (en) 1987-11-02
LU86932A1 (fr) 1988-01-20
DE3720510A1 (de) 1988-01-07
DK173508B1 (da) 2001-01-15
IL83032A0 (en) 1987-12-20
FI872871L (fi) 1988-01-02
US4867977A (en) 1989-09-19
SG123192G (en) 1993-02-19
DE3720510C2 (de) 2002-12-19
NO175041C (instruction) 1994-08-24
CH674935A5 (instruction) 1990-08-15
CA1305057C (en) 1992-07-14
AT392588B (de) 1991-04-25
BE1007686A4 (fr) 1995-10-03
AU597992B2 (en) 1990-06-14
KR950014449B1 (ko) 1995-11-28
KR880001295A (ko) 1988-04-22
GB2192131B (en) 1990-04-04
GB8715216D0 (en) 1987-08-05
NO872712L (no) 1988-01-04
DK333487A (da) 1988-01-02
FI872871A0 (fi) 1987-06-29
GB2192131A (en) 1988-01-06
NO175041B (no) 1994-05-16
FR2600893B1 (fr) 1990-01-12
NL194749C (nl) 2003-02-04
CY1684A (en) 1993-10-10
IT1216829B (it) 1990-03-14
DK333487D0 (da) 1987-06-29
MY101750A (en) 1992-01-17
ZA874769B (en) 1989-02-22
HU199283B (en) 1990-02-28
NL8701440A (nl) 1988-02-01
IE871730L (en) 1988-01-01
FR2600893A1 (fr) 1988-01-08
PH25430A (en) 1991-07-01
FI89329B (fi) 1993-06-15
SE502567C2 (sv) 1995-11-13
PT85212B (pt) 1990-03-30
NL194749B (nl) 2002-10-01
HUT49481A (en) 1989-10-30
SE8702712D0 (sv) 1987-06-30
FI89329C (fi) 1993-09-27
IL83032A (en) 1991-05-12

Similar Documents

Publication Publication Date Title
HK80393A (en) Pharmaceutical compositions containing calcium salts
IL86837A (en) Repairing agent for cells and tissues containing as active ingredient an n-acetylneuraminic acid salt
GR3003685T3 (instruction)
EP0184942A3 (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
NZ216632A (en) Multi-component, aqueous polymer compositions containing c 16 + aliphatic surface active compound as evaporation retarding agent
AU4936890A (en) Medicament containing dihydrolipoic acid as active substance
IT1241168B (it) Composizione orale antibatterica antiplacca contenente un copolimero di acido stiren fosfonico.
AU1116088A (en) Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
AU2616088A (en) Prosthesis-fixing cement-forming composition containing cell growth stimulant
AU6969887A (en) Calcium supplement tablet containing sodium lauryl sulphate
AU5425886A (en) Anticalculus oral composition containing phosphonoformic acid
CA2008509A1 (en) Stabilizing System for Solid Dosage Forms
IL78431A0 (en) Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid and salts thereof,their production and pharmaceutical compositions containing them
CA2007260A1 (en) Effervescent analgesic antacid composition having reduced sodium content (ms-1569-cip-11)
DK491385A (da) 1,2,4-triazolocarbamater og deres syreadditionssalte, fremgangsmaader til deres fremstilling og laegemidler indeholdende saadanne forbindelser
IL83049A (en) 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL84877A0 (en) Pharmaceutical compositions containing 13-cis-retinoic acid
AU570558B2 (en) Topical pharmaceutical preparation containing calcium and potassium salts
AU7253587A (en) Nylon containing calcium salts
AU570446B2 (en) Dipyridamole controlled release compositon
EP0289951A3 (en) Sulfur dissolving composition
DE3175699D1 (en) Salts and aqueous solutions of 6-methylamino-4-oxo-10-propyl-4h-pyrano(3,2-g)-quinoline-2,8-di-carboxylic acid and pharmaceutical compositions containing such salts and solutions
AU578104B2 (en) Pharmaceutical composition of peroxydiphosphoric acid derivatives
IL76897A (en) Crystalline 2-penem-3-carboxylic acid derivative,its manufacture and pharmaceutical compositions containing it
IE44704L (en) ß-LACTAM ANTIBIOTIC

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)